BioSpace News Archive

Myovant Sciences (NYSE: MYOV), a healthcare company focused on developing innovative treatments for women’s health and prostate cancer, today announced that the Phase 3 HERO study of once-daily, oral relugolix (120 mg) met its primary efficacy endpoint and all six key secondary endpoints in men with advanced prostate cancer.

Diverse Biotech, Inc. www.diversebiotech.com, has announced it has opened its Headquarters at the Pennsylvania Biotechnology Center which is a prominent incubator for small growing life sciences companies in Doylestown, PA.

Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces a new clinical study illustrating the successful treatment of large (3-5cm) and massive (5cm+) rotator cuff tears using its REGENETEN Bioinductive Implant

Today, Agilent Technologies and Guangzhou Burning Rock Medical Laboratory Co., Ltd. (“Burning Rock Dx”) jointly held a product launch event on Magnis BR, an automated next generation sequencing (NGS) library preparation system, to announce that Magnis BR is formally launched.

Biosight Ltd., a pharmaceutical development company developing innovative therapeutics for hematological malignancies and disorders, announced that results from an ongoing Phase 2b clinical trial of BST-236 (aspacytarabine) for treatment of acute myeloid leukemia (AML

Nearly three-quarters (74%) of Americans who contract the flu call out sick from work or school and more than a third (35%) missed more than a week last year, reducing productivity all over the country.

Antares Pharma, Inc. announced that it has entered into a global agreement with Idorsia Pharmaceuticals Ltd. to develop a novel, drug-device product combining selatogrel, Idorsia’s potent, fast-acting and highly selective P2Y12 receptor antagonist under development, with the Antares subcutaneous QuickShot® auto injector.

Baring Private Equity Asia announced that its affiliated private equity funds have agreed to acquire Lumenis, a leading provider of specialty energy-based medical devices across the fields of aesthetics, urology, ophthalmology, ENT and gynecology from XIO.

World leader in production solutions for additive manufacturing demonstrates latest innovations for Healthcare, Aerospace, and Automotive industries

Leading sleep organizations urge for more federal funding for sleep research and awareness